General Information of Drug (ID: DMGVJLB)

Drug Name
GMA-161 Drug Info
Indication
Disease Entry ICD 11 Status REF
Idiopathic thrombocytopenic purpura 3B64.10 Approved (orphan drug) [1]
Cross-matching ID
TTD Drug ID
DMGVJLB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GTB-3550 DMK2RIB Acute myelogenous leukaemia 2A41 Phase 1/2 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Immunoglobulin gamma Fc receptor III (FCGR3) TT7KTSR FCG3A_HUMAN; FCG3B_HUMAN Antagonist [1]

References

1 Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54.
2 Clinical pipeline report, company report or official report of GT Biopharma.